title: Effects of intratracheal administration of nuclear factor-kappaB decoy oligodeoxynucleotides on long-term cigarette smoke-induced lung inflammation and pathology in mice.
abstract: To determine if nuclear factor-kappaB (NF-kappaB) activation may be a key factor in lung inflammation and respiratory dysfunction, we investigated whether NF-kappaB can be blocked by intratracheal administration of NF-kappaB decoy oligodeoxynucleotides (ODNs), and whether decoy ODN-mediated NF-kappaB inhibition can prevent smoke-induced lung inflammation, respiratory dysfunction, and improve pathological alteration in the small airways and lung parenchyma in the long-term smoke-induced mouse model system. We also detected changes in transcriptional factors. In vivo, the transfection efficiency of NF-kappaB decoy ODNs to alveolar macrophages in BALF was measured by fluorescein isothiocyanate (FITC)-labeled NF-kappaB decoy ODNs and flow cytometry post intratracheal ODN administration. Pulmonary function was measured by pressure sensors, and pathological changes were assessed using histology and the pathological Mias software. NF-kappaB and activator protein 1(AP-1) activity was detected by the electrophoretic motility shift assay (EMSA). Mouse cytokine and chemokine pulmonary expression profiles were investigated by enzyme-linked immunosorbent assay (ELISA) in bronchoalveolar lavage fluid (BALF) and lung tissue homogenates, respectively, after repeated exposure to cigarette smoke. After 24 h, the percentage of transfected alveolar macrophages was 30.00 +/- 3.30%. Analysis of respiratory function indicated that transfection of NF-kappaB decoy ODNs significantly impacted peak expiratory flow (PEF), and bronchoalveolar lavage cytology displayed evidence of decreased macrophage infiltration in airways compared to normal saline-treated or scramble NF-kappaB decoy ODNs smoke exposed mice. NF-kappaB decoy ODNs inhibited significantly level of macrophage inflammatory protein (MIP) 1alpha and monocyte chemoattractant protein 1(MCP-1) in lung homogenates compared to normal saline-treated smoke exposed mice. In contrast, these NF-kappaB decoy ODNs-treated mice showed significant increase in the level of tumor necrosis factor-alpha(TNF-alpha) and pro-MMP-9(pro-matrix metalloproteinase-9) in mice BALF. Further measurement revealed administration of NF-kappaB decoy ODNs did not prevent pathological changes. These findings indicate that NF-kappaB activation play an important role on the recruitment of macrophages and pulmonary dysfunction in smoke-induced chronic lung inflammation, and with the exception of NF-kappaB pathway, there might be complex mechanism governing molecular dynamics of pro-inflammatory cytokines expression and structural changes in small airways and pulmonary parenchyma in vivo.
authors.affiliation: Department of Respiratory Medicine, Peking University Third Hospital, Beijing, PR China. cloris.lee@hotmail.com
authors.forename: Yu-Tao
authors.initials: YT
authors.lastname: Li
authors.forename: Bei
authors.initials: B
authors.lastname: He
authors.forename: Yu-Zhu
authors.initials: YZ
authors.lastname: Wang
authors.forename: Jing
authors.initials: J
authors.lastname: Wang
mesh_terms: D000818:Animals; D008168:Lung; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D016328:NF-kappa B / Q000235:genetics / Q000378:metabolism*; D009838:Oligodeoxyribonucleotides / Q000008:administration & dosage; D011014:Pneumonia / Q000209:etiology* / Q000378:metabolism*; D012906:Smoke / Q000009:adverse effects*; D014026:Nicotiana / Q000633:toxicity*; D014132:Trachea; D014162:Transfection / Q000379:methods
chemical_list: D016328:NF-kappa B; D009838:Oligodeoxyribonucleotides; D012906:Smoke
references.citation: Respir Res. 2005 Jan 21;6:11
references.pmid: 15663794
references.citation: Thorax. 2002 Sep;57(9):830-4
references.pmid: 12200530
references.citation: Int J Exp Pathol. 2006 Oct;87(5):373-81
references.pmid: 16965565
references.citation: J Clin Invest. 2004 Dec;114(12):1790-9
references.pmid: 15599404
references.citation: Mod Pathol. 2003 Jan;16(1):1-7
references.pmid: 12527706
references.citation: J Pharmacol Exp Ther. 2007 May;321(2):734-42
references.pmid: 17322026
references.citation: Eur Respir J. 1998 Jul;12(1):221-34
references.pmid: 9701442
references.citation: J Clin Invest. 1990 Nov;86(5):1496-502
references.pmid: 2173721
references.citation: EMBO J. 1991 Aug;10(8):2247-58
references.pmid: 2065663
references.citation: Am J Respir Cell Mol Biol. 2003 Jan;28(1):12-24
references.pmid: 12495928
references.citation: Eur Respir J. 2003 Oct;22(4):672-88
references.pmid: 14582923
references.citation: Chest. 2002 May;121(5 Suppl):209S-218S
references.pmid: 12010854
references.citation: Am J Physiol Lung Cell Mol Physiol. 2008 Jun;294(6):L1149-57
references.pmid: 18408070
references.citation: Mol Pharmacol. 2005 Apr;67(4):1018-25
references.pmid: 15576632
references.citation: Eur Respir J. 2005 Jan;25(1):15-22
references.pmid: 15640318
references.citation: Biochimie. 2001 Nov-Dec;83(11-12):1029-39
references.pmid: 11879731
references.citation: J Immunol. 1998 Sep 15;161(6):3071-6
references.pmid: 9743373
references.citation: Inhal Toxicol. 2009 Jun;21(7):641-7
references.pmid: 19235541
references.citation: N Engl J Med. 1978 Jun 8;298(23):1277-81
references.pmid: 651978
references.citation: Am J Physiol Lung Cell Mol Physiol. 2001 Jan;280(1):L39-49
references.pmid: 11133493
references.citation: Eur Respir J. 1999 Jul;14(1):160-5
references.pmid: 10489845
references.citation: Thorax. 2003 Apr;58(4):348-51
references.pmid: 12668802
references.citation: Immunity. 2003 Jul;19(1):71-82
references.pmid: 12871640
references.citation: Am Rev Respir Dis. 1967 May;95(5):752-64
references.pmid: 5337140
references.citation: N Engl J Med. 1974 Oct 10;291(15):755-8
references.pmid: 4414996
references.citation: J Neuroinflammation. 2008 Aug 15;5:35
references.pmid: 18706086
references.citation: J Virol. 2006 Aug;80(16):8248-58
references.pmid: 16873280
references.citation: Clin Chem. 1999 Jan;45(1):7-17
references.pmid: 9895331
references.citation: Am J Respir Crit Care Med. 2005 Oct 15;172(8):962-71
references.pmid: 16002568
references.citation: Mol Cell Biol. 2004 Jun;24(12):5496-509
references.pmid: 15169910
references.citation: J Clin Invest. 2001 Jan;107(1):3-6
references.pmid: 11134170
references.citation: Nature. 1994 Aug 18;370(6490):555-7
references.pmid: 8052310
references.citation: Zhonghua Yi Xue Za Zhi. 2001 Nov 25;81(22):1360-4
references.pmid: 11930628
references.citation: Am J Respir Cell Mol Biol. 1999 Feb;20(2):189-98
references.pmid: 9922209
references.citation: Environ Health Perspect. 1985 Dec;64:111-26
references.pmid: 3007083
references.citation: J Biochem Mol Biol. 2003 Jan 31;36(1):95-109
references.pmid: 12542980
references.citation: Chest. 2002 May;121(5 Suppl):156S-159S
references.pmid: 12010845
references.citation: Respir Res. 2007 Nov 14;8:81
references.pmid: 18001475
references.citation: Free Radic Biol Med. 2003 Oct 1;35(7):697-710
references.pmid: 14583334
references.citation: Am Rev Respir Dis. 1989 Feb;139(2):308-12
references.pmid: 2913883
references.citation: J Immunol. 1985 Sep;135(3):1766-71
references.pmid: 3874905
references.citation: Am J Respir Cell Mol Biol. 2002 Jan;26(1):152-9
references.pmid: 11751215
references.citation: Eur Respir J. 2002 Sep;20(3):556-63
references.pmid: 12358328
references.citation: Drug Metab Dispos. 1997 Nov;25(11):1272-81
references.pmid: 9351904
references.citation: Pulm Pharmacol Ther. 2003;16(5):247-77
references.pmid: 12877818
references.citation: Annu Rev Immunol. 1998;16:225-60
references.pmid: 9597130
references.citation: Am J Physiol Lung Cell Mol Physiol. 2001 Apr;280(4):L716-23
references.pmid: 11238012
references.citation: Am J Respir Crit Care Med. 1998 Oct;158(4):1277-85
references.pmid: 9769292
references.citation: J Biol Chem. 2005 Oct 28;280(43):36510-7
references.pmid: 16123045
references.citation: Am J Respir Crit Care Med. 2002 Apr 1;165(7):996-1004
references.pmid: 11934728
references.citation: Mol Cell Biol. 2004 Sep;24(17):7806-19
references.pmid: 15314185
references.citation: Ann N Y Acad Sci. 2005 May;1041:314-6
references.pmid: 15956726
references.citation: J Clin Invest. 2000 Nov;106(9):1071-5
references.pmid: 11067859
references.citation: Am J Physiol. 1999 Dec;277(6):L1067-88
references.pmid: 10600876
references.citation: Eur Respir J Suppl. 2001 Dec;34:50s-59s
references.pmid: 12392035
references.citation: Annu Rev Immunol. 1996;14:649-83
references.pmid: 8717528
references.citation: Lab Invest. 1998 Sep;78(9):1077-87
references.pmid: 9759652
references.citation: J Immunol. 2004 Nov 1;173(9):5766-75
references.pmid: 15494529
references.citation: Biochem J. 2004 Jul 15;381(Pt 2):413-22
references.pmid: 15086314
references.citation: BMC Genomics. 2005 Sep 28;6:137
references.pmid: 16191192
references.citation: Am J Respir Cell Mol Biol. 1997 Jul;17(1):3-9
references.pmid: 9224203
references.citation: Am Rev Respir Dis. 1985 May;131(5):764-9
references.pmid: 4003921
references.citation: Respir Res. 2004 Sep 15;5:12
references.pmid: 15377395
references.citation: Science. 1990 Nov 16;250(4983):997-1000
references.pmid: 2237444